<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="present research was to compare the effectiveness and tolerability of" exact="melatonin" post="and amitriptyline in pediatric migraine prevention. Materials &amp;amp; Methods:"/>
 <result pre="was to compare the effectiveness and tolerability of melatonin and" exact="amitriptyline" post="in pediatric migraine prevention. Materials &amp;amp; Methods: In a"/>
 <result pre="Yazd-Iran from 2013-2014, were randomly allocated to receive 1 mg/kg" exact="amitriptyline" post="or 0.3 mg/kg melatonin for three consecutive months. Results:"/>
 <result pre="randomly allocated to receive 1 mg/kg amitriptyline or 0.3 mg/kg" exact="melatonin" post="for three consecutive months. Results: Forty one girls (51.3%)"/>
 <result pre="yr were evaluated. Good response was seen in 82.5% of" exact="amitriptyline" post="and 62%.5 of melatonin groups and amitriptyline was statistically"/>
 <result pre="response was seen in 82.5% of amitriptyline and 62%.5 of" exact="melatonin" post="groups and amitriptyline was statistically significant more effective ("/>
 <result pre="in 82.5% of amitriptyline and 62%.5 of melatonin groups and" exact="amitriptyline" post="was statistically significant more effective ( P=0.04). Severity, duration"/>
 <result pre="Pediatric Migraine Disability Assessment score (PedMIDAS) of headache reduced with" exact="melatonin" post="from 6.05±1.63 to 4.03±1.54 scores, from 2.06±1.18 to 1.41±"/>
 <result pre="scores, respectively. Severity, duration and PedMIDAS of headache decreased with" exact="amitriptyline" post="from 6.41±1.67to 2.25±1.21, from 2.55 ±1.85to 0.56±0.51h, and from"/>
 <result pre="disability of headache. Daily sleepiness was seen in 7.5% of" exact="melatonin" post="group as a side effect and adverse events were"/>
 <result pre="side effect and adverse events were seen in 22.5% of" exact="amitriptyline" post="group including daily sleepiness in four, constipation in three"/>
 <result pre="four, constipation in three and fatigue in two children and" exact="melatonin" post="was safer than amitriptyline (value = 0.04). Conclusion: Amitriptyline"/>
 <result pre="and fatigue in two children and melatonin was safer than" exact="amitriptyline" post="(value = 0.04). Conclusion: Amitriptyline and melatonin are effective"/>
 <result pre="was safer than amitriptyline (value = 0.04). Conclusion: Amitriptyline and" exact="melatonin" post="are effective and safe in pediatric migraine prophylaxis but"/>
 <result pre="melatonin are effective and safe in pediatric migraine prophylaxis but" exact="amitriptyline" post="can be considered as a more effective drug. Key"/>
 <result pre="guideline for migraine prevention in children does not exist and" exact="flunarizine" post="and recently topiramate have been approved by Food and"/>
 <result pre="prevention in children does not exist and flunarizine and recently" exact="topiramate" post="have been approved by Food and Drug Administration in"/>
 <result pre="is the most common migraine preventive drug in children, but" exact="amitriptyline" post="should not be used in children with rapid or"/>
 <result pre="compound which is mainly produced in the pineal gland from" exact="tryptophan" post="amino acid and secreted into the blood and cerebrospinal"/>
 <result pre="modulation of the circadian rhythm of sleep .The level of" exact="melatonin" post="might be decreased in migraine headaches and it may"/>
 <result pre="effective drug in treatment of migraine headaches. Possible mechanisms of" exact="melatonin" post="in treatment of headache might be related to its"/>
 <result pre="toxic free radical scavenging effects, decrease of pro-inflammatory cytokine upregulation," exact="nitric oxide" post="synthase activity and inhibition of dopamine release, stabilizing of"/>
 <result pre="pro-inflammatory cytokine upregulation, nitric oxide synthase activity and inhibition of" exact="dopamine" post="release, stabilizing of membrane, glutamate neurotoxicity protection and neurovascular"/>
 <result pre="protection and neurovascular regulation&quot; ( 5). Effectiveness of three-milligram oral" exact="melatonin" post="at bedtime in 14 children with recurrent migraine headache,"/>
 <result pre="We aimed to test the hypothesis that whether or not" exact="melatonin" post="was superior to amitriptyline for migraine prophylaxis in 5-15"/>
 <result pre="the hypothesis that whether or not melatonin was superior to" exact="amitriptyline" post="for migraine prophylaxis in 5-15 yr-old children suffer frequent"/>
 <result pre="Clinic. We wanted to compare the effectiveness and tolerability of" exact="amitriptyline" post="and melatonin for pediatric migraine prevention. Materials and Methods"/>
 <result pre="wanted to compare the effectiveness and tolerability of amitriptyline and" exact="melatonin" post="for pediatric migraine prevention. Materials and Methods In a"/>
 <result pre="single-blind clinical, open-label, parallel group study, effectiveness and tolerability of" exact="amitriptyline" post="and melatonin for migraine prophylaxis in 5-15 yr old"/>
 <result pre="open-label, parallel group study, effectiveness and tolerability of amitriptyline and" exact="melatonin" post="for migraine prophylaxis in 5-15 yr old children who"/>
 <result pre="monthly headache frequency during the follow-up period) of 70% for" exact="melatonin" post="in pilot study ( 5) and an effect size"/>
 <result pre="were randomly allocated to two groups to receive 0.3 mg/kg" exact="melatonin" post="(maximum 6 mg) or 1mg/kg/day amitriptyline (maximum 50 mg)"/>
 <result pre="to receive 0.3 mg/kg melatonin (maximum 6 mg) or 1mg/kg/day" exact="amitriptyline" post="(maximum 50 mg) for 90 consecutive days. In both"/>
 <result pre="traditional medicine during the follow up period. Measurement equipment of" exact="amitriptyline" post="and melatonin blood level were not accessible in our"/>
 <result pre="during the follow up period. Measurement equipment of amitriptyline and" exact="melatonin" post="blood level were not accessible in our center. Safety"/>
 <result pre="The participants were allowed to use nonsteroidal anti-inflammatory analgesics (" exact="acetaminophen" post="or ibuprofen) for alleviation of moderate to severe headache"/>
 <result pre="P values of less than 0.05. Results Three children in" exact="melatonin" post="group and four patients in amitriptyline group loosed to"/>
 <result pre="Results Three children in melatonin group and four patients in" exact="amitriptyline" post="group loosed to follows: up and two patients in"/>
 <result pre="amitriptyline group loosed to follows: up and two patients in" exact="melatonin" post="group and two in amitriptyline discontinued drug usage during"/>
 <result pre="up and two patients in melatonin group and two in" exact="amitriptyline" post="discontinued drug usage during follow up period. Finally, 41girls"/>
 <result pre="monthly headache frequency) was seen in 25 patients (62.5%) of" exact="melatonin" post="(95% confidence interval: 0.45–0.71) and in 33 (82.5%) of"/>
 <result pre="melatonin (95% confidence interval: 0.45–0.71) and in 33 (82.5%) of" exact="amitriptyline" post="group (95% confidence interval: 0.75 –0.93) and amitriptyline was"/>
 <result pre="(82.5%) of amitriptyline group (95% confidence interval: 0.75 –0.93) and" exact="amitriptyline" post="was statistically significantly more effective ( P=0.04). Comparison of"/>
 <result pre="P=0.04). Comparison of headache characteristics before and after treatment in" exact="melatonin" post="and amitriptyline groups is presented in Table 2 and"/>
 <result pre="of headache characteristics before and after treatment in melatonin and" exact="amitriptyline" post="groups is presented in Table 2 and Table 3"/>
 <result pre="after treatment, which indicates that amitriptyline, was more effective than" exact="melatonin" post="in reduction of monthly frequency, severity, duration and disability"/>
 <result pre="number of analgesic usage was not statistically significant different in" exact="melatonin" post="and amitriptyline groups. Daily sleepiness, as a side effect,"/>
 <result pre="analgesic usage was not statistically significant different in melatonin and" exact="amitriptyline" post="groups. Daily sleepiness, as a side effect, was seen"/>
 <result pre="as a side effect, was seen in 7.5% (N=3) of" exact="melatonin" post="group. In 22.5% (N=9) of amitriptyline group, adverse events"/>
 <result pre="in 7.5% (N=3) of melatonin group. In 22.5% (N=9) of" exact="amitriptyline" post="group, adverse events were seen including daily sleepiness in"/>
 <result pre="in two children. The adverse events were more frequent in" exact="amitriptyline" post="group (value = 0.04). Excessive daytime sleepiness as a"/>
 <result pre="pediatric population. In the present research, effectiveness and tolerability of" exact="amitriptyline" post="and melatonin for pediatric migraine prophylaxis in 5-15 yr"/>
 <result pre="In the present research, effectiveness and tolerability of amitriptyline and" exact="melatonin" post="for pediatric migraine prophylaxis in 5-15 yr old children"/>
 <result pre="compared. The results showed that both drugs were effective, but" exact="amitriptyline" post="was more effective and melatonin was safer than amitriptyline."/>
 <result pre="both drugs were effective, but amitriptyline was more effective and" exact="melatonin" post="was safer than amitriptyline. Table 1 Comparison of some"/>
 <result pre="2 Comparison of headache characteristics before and after treatment in" exact="melatonin" post="group Group Before treatment (mean ±SD) After treatment (mean"/>
 <result pre="3 Comparison of headache characteristics before and after treatment in" exact="amitriptyline" post="group Group Before treatment (mean ±SD) After treatment (mean"/>
 <result pre="0.5 Independent t-test In 18-65 yr old migraineurs in Brazil," exact="melatonin" post="and amitriptyline in comparison with placebo-decreased frequency of migraine"/>
 <result pre="t-test In 18-65 yr old migraineurs in Brazil, melatonin and" exact="amitriptyline" post="in comparison with placebo-decreased frequency of migraine headache and"/>
 <result pre="comparison with placebo-decreased frequency of migraine headache and tolerability of" exact="melatonin" post="was more than amitriptyline ( 11). Effectiveness of melatonin"/>
 <result pre="of migraine headache and tolerability of melatonin was more than" exact="amitriptyline" post="( 11). Effectiveness of melatonin in reduction of monthly"/>
 <result pre="of melatonin was more than amitriptyline ( 11). Effectiveness of" exact="melatonin" post="in reduction of monthly frequency, severity, duration and disability"/>
 <result pre="monthly headache frequency was seen in 62.5% of children in" exact="melatonin" post="group. However, the rate of good response had been"/>
 <result pre="and excessive sleep can both cause migraine ( 12) and" exact="melatonin" post="irregular production has some links to sleep disorders, linked"/>
 <result pre="headache might cause sleeplessness and daytime drowsiness and effectiveness of" exact="melatonin" post="in control of migraine headache might be related to"/>
 <result pre="of sleep circadian rhythm ( 13). In the present study," exact="melatonin" post="was tolerated well and no life-threatening clinical side effects"/>
 <result pre="clinical side effects were seen in kids and safety of" exact="melatonin" post="similar to other researches ( 6, 14, 15). The"/>
 <result pre="16, 17). In the present research, 82.5% of patients in" exact="amitriptyline" post="group showed good response. Positive response rate for amitriptyline"/>
 <result pre="in amitriptyline group showed good response. Positive response rate for" exact="amitriptyline" post="was also 89% in Lewis et al. study ("/>
 <result pre="et al study in adults ( 20). In Dhaka, Bangladesh," exact="amitriptyline" post="was effective and with minimal side effects in prevention"/>
 <result pre="in prevention of migraine ( 21). However, in the USA," exact="amitriptyline" post="was more effective than placebo in prevention of migraine"/>
 <result pre="weeks ( 22). In this study, 22.5% of children in" exact="amitriptyline" post="group showed side effects such as daily sleepiness, constipation,"/>
 <result pre="as daily sleepiness, constipation, malaise, and majority of them tolerated" exact="amitriptyline" post="well and without life- threatening side effects. However, other"/>
 <result pre="techniques. In infants and younger kids who cannot swallow tablets," exact="cyproheptadine" post="might be superior. Amitriptyline as one of tricyclic antidepressants"/>
 <result pre="side effects. In comorbid situations such as migraine and depression," exact="amitriptyline" post="might be more beneficial and abundance of amitriptyline adverse"/>
 <result pre="and depression, amitriptyline might be more beneficial and abundance of" exact="amitriptyline" post="adverse events such as sleepiness can be decreased by"/>
 <result pre="research can be viewed as promising for it showed that" exact="amitriptyline" post="and melatonin are effective and without life-threatening adverse events"/>
 <result pre="be viewed as promising for it showed that amitriptyline and" exact="melatonin" post="are effective and without life-threatening adverse events in pediatric"/>
 <result pre="and without life-threatening adverse events in pediatric migraine prophylaxis but" exact="amitriptyline" post="was superior to melatonin and melatonin was tolerated better."/>
 <result pre="events in pediatric migraine prophylaxis but amitriptyline was superior to" exact="melatonin" post="and melatonin was tolerated better. Acknowledgment This study was"/>
 <result pre="pediatric migraine prophylaxis but amitriptyline was superior to melatonin and" exact="melatonin" post="was tolerated better. Acknowledgment This study was funded by"/>
 <result pre="Fallah R Shoroki FF Ferdosian F Safety and efficacy of" exact="melatonin" post="in pediatric migraine prophylaxis Curr Drug Saf 2015 10"/>
 <result pre="Divanizadeh MS Karimi M Mirouliaei M Shamszadeh A Topiramate and" exact="propranolol" post="for prophylaxis of migraine Indian J Pediatr 2013 80"/>
 <result pre="M Gonçalves A Double-blind, placebo controlled, randomized clinical trial comparing" exact="melatonin" post="3 mg, amitriptyline 25 mg and placebo for migraine"/>
 <result pre="Double-blind, placebo controlled, randomized clinical trial comparing melatonin 3 mg," exact="amitriptyline" post="25 mg and placebo for migraine prevention Neurology February"/>
 <result pre="15 Sánchez-Barceló EJ Mediavilla MD Reiter RJ Clinical uses of" exact="melatonin" post="in pediatrics Int J Pediatr 2011 2011 892624 21760817"/>
 <result pre="Hershey AD Powers SW Bentti AL Degrauw TJ Effectiveness of" exact="amitriptyline" post="in the prophylactic management of childhood headaches Headache 2000"/>
 <result pre="MA Alam MN Miah AH Uddin MS Efficacy of amitriptyline," exact="pizotifen" post="and propranolol in the prevention of migraine Mymensingh Med"/>
 <result pre="MN Miah AH Uddin MS Efficacy of amitriptyline, pizotifen and" exact="propranolol" post="in the prevention of migraine Mymensingh Med J 2013"/>
</results>
